AstraZeneca and Daiichi Sankyo win U.S. approval for breast cancer drug
The Food and Drug Administration approved the drug for patients with advanced breast tumors whose cells bear a certain genetic signature.
Tomas Kauer - News Moderator 
The Food and Drug Administration approved the drug for patients with advanced breast tumors whose cells bear a certain genetic signature.
